Detalhe da pesquisa
1.
Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial.
Blood
; 141(16): 1971-1981, 2023 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36626583
2.
Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy.
Drug Resist Updat
; 74: 101068, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402670
3.
Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions.
Cancer Immunol Immunother
; 73(2): 31, 2024 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279998
4.
Functional characterization of D-type cyclins involved in cell division in rice.
BMC Plant Biol
; 24(1): 157, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38424498
5.
Long-term outcomes with HLX01 (HanliKang®), a rituximab biosimilar, in previously untreated patients with diffuse large B-cell lymphoma: 5-year follow-up results of the phase 3 HLX01-NHL03 study.
BMC Cancer
; 24(1): 124, 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267866
6.
LncRNA ADAMTS9-AS1 inhibits the stemness of lung adenocarcinoma cells by regulating miR-5009-3p/NPNT axis.
Genomics
; 115(3): 110596, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36870548
7.
Reduced-dose post-transplant cyclophosphamide plus low-dose post-transplant anti-thymocyte globulin as graft-versus-host disease prophylaxis with fludarabine-busulfan-cytarabine conditioning in haploidentical peripheral blood stem cell transplantation: A multicentre, randomized controlled clinical trial.
Br J Haematol
; 200(2): 210-221, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200642
8.
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study.
Am J Hematol
; 98(4): 571-579, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36683422
9.
Advances in the study of CD47-based bispecific antibody in cancer immunotherapy.
Immunology
; 167(1): 15-27, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35575882
10.
Targeting macrophages: a novel treatment strategy in solid tumors.
J Transl Med
; 20(1): 586, 2022 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36510315
11.
Evidence of pyroptosis and ferroptosis extensively involved in autoimmune diseases at the single-cell transcriptome level.
J Transl Med
; 20(1): 363, 2022 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35962439
12.
Crystal Structure of Human CD47 in Complex with Engineered SIRPα.D1(N80A).
Molecules
; 27(17)2022 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36080360
13.
[Analysis the influence factors of treatment free remission outcome with chronic myeloid leukemia patients who discontinued tyrosine kinase inhibitors].
Zhonghua Yi Xue Za Zhi
; 102(20): 1523-1529, 2022 May 31.
Artigo
em Zh
| MEDLINE | ID: mdl-35692068
14.
miR-17-3p promotes the proliferation of multiple myeloma cells by downregulating P21 expression through LMLN inhibition.
Int J Cancer
; 148(12): 3071-3085, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33609405
15.
Research progress on exosomes derived from mesenchymal stem cells in hematological malignancies.
Hematol Oncol
; 39(2): 162-169, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32869900
16.
Characterization of CD103+ CD8+ tissue-resident T cells in esophageal squamous cell carcinoma: may be tumor reactive and resurrected by anti-PD-1 blockade.
Cancer Immunol Immunother
; 69(8): 1493-1504, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32285170
17.
Correction to: The predictive value of dynamic monitoring of peripheral blood lymphocyte to monocyte ratio in patients with extranodal NK/T cell lymphoma.
Cancer Cell Int
; 20: 21, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31969793
18.
IgH translocation with undefined partners is associated with superior outcome in multiple myeloma patients.
Eur J Haematol
; 105(3): 326-334, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32421883
19.
ENGINE: a Phase III randomized placebo controlled study of enzastaurin/R-CHOP as frontline therapy in high-risk diffuse large B-cell lymphoma patients with the genomic biomarker DGM1.
Future Oncol
; 16(15): 991-999, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32250167
20.
Recent updates on CAR T clinical trials for multiple myeloma.
Mol Cancer
; 18(1): 154, 2019 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31684964